September 22, 2009Open Access

Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This study demonstrates the need to detect partial C within C+ SCD patients and to prevent immunization. A larger number of Afro-Caribbeans donors is needed to provide these patients with C- RBCs.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Tournamille et al. (Tue,) studied this question.

synapsesocial.com/papers/69d86086c025a7c015bedb42 https://doi.org/https://doi.org/10.1111/j.1537-2995.2009.02382.x

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 (Plerixafor)+G-CSF vs. G-CSF+Placebo for Mobilization in Multiple Myeloma (MM) Patients for Autologous Hematopoietic Stem Cell (aHSC) Transplantation.2007 · 35 citations
2Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler2005 · 82 citations
3Molecular basis of the altered antigenic expression of RhD in weak D(Du) and RhC/e in RN phenotypes1996 · 88 citations
4Stroke Prevention Trial in Sickle Cell Anemia1998 · 275 citations
5Autoantibodies induced by blood transfusion2004 · 70 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo